Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MAPKs: new targets for neurodegeneration

1 Apr 2003

Abstract excerpt

Neurodegenerative diseases remain a huge unmet pharmaceutical need. For some diseases such as Parkinson's disease, there are currently only palliative therapies, and for others such as Alzheimer's disease there are no proven therapies on the market that have any significant impact on disease progression. Recent work has suggested that cell death may play a key role in a number of neurodegenerative diseases, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12667097
DOI: 10.1517/14728222.7.2.187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MAPKs: new targets for neurodegenerationPMID 12667097Read ↗

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s DiseasesSemantic proximity Read ↗

The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New DevelopmentsSemantic proximity Read ↗

Protein Kinases and Parkinson’s DiseaseSemantic proximity Read ↗

The Role of c‐Jun N‐Terminal Kinase (JNK) in Parkinson's DiseaseSemantic proximity Read ↗

Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s DiseaseSemantic proximity Read ↗

Unraveling the AKT/ERK cascade and its role in Parkinson diseaseSemantic proximity Read ↗

Protein Kinases and Neurodegenerative DiseasesSemantic proximity Read ↗

Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: Relevance to oxidative stress and neuroinflammation in Parkinson's diseaseSemantic proximity Read ↗

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative DiseaseSemantic proximity Read ↗

Characterizing the role of the dark kinome in neurodegenerative disease – A mini reviewSemantic proximity Read ↗

A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and MtorSemantic proximity Read ↗

Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.